Recent analyses have documented what many in the pharmaceutical industry quietly suspected: China’s drug discovery output has achieved parity with the United States, tripling from roughly 30 new medicines in 2013 to over 400 a decade later. This is remarkable not merely as an economic indicator, but as a live experiment testing competing theories of […]

The post China’s beautiful biotech chaos vs West’s elegant paralysis appeared first on Asia Times.